Diagnostic News and Research

RSS

MDI raises $1.4M as part of follow-on to its $3.3M Series C financing round

Molecular Detection Inc., a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced the first close of a new financing. The financing was led by MentorTech Ventures II, LP and included Robin Hood Ventures, Elm Spring Holdings and the Mid-Atlantic Angel Group Fund I and II, LP, all existing investors. The company raised $1.4 million as part of a follow-on to its $3.3 million Series C round announced in late 2009.

23 Jun 2010

German IVF Register reports one-millionth treatment cycle in reproductive medicine

Dr. Klaus Buhler, President of the German IVF Register, has reported the one-millionth treatment cycle in reproductive medicine recorded by the IVF Register in Germany this year. Presently, ninety per cent of all centers for in-vitro fertilization (IVF) in Germany collect data from reproductive treatments using RecDate Advance by Merck Serono - a database system developed by the IT consulting firm CRITEX, and marketed under the name MedITEX IVF.

23 Jun 2010

imec researchers demonstrate biosensors that detect extremely low concentrations of disease markers

Researchers at the nanotechnology research centre imec have demonstrated biosensors based on novel nanostructure geometries that increase the sensitivity and allow to detect extremely low concentrations of specific disease markers. This paves the way to early diagnostics of for example cancer by detecting low densities of cancer markers in human blood samples.

23 Jun 2010

Toshiba announces availability of Aegis breast imaging workstation with MR products

Improving the ability to efficiently process MR images used for breast cancer analysis, the AegisTM breast imaging workstation is now available with Toshiba America Medical Systems' MR products. The Aegis workstation was developed with the distinct needs of radiologists and technologists in mind, offering flexibility and workflow efficiency.

23 Jun 2010

A*STAR physicist receives prestigious 2010 IEEE Medal for Innovations in Healthcare Technology

Physicist David William Townsend will be honoured with the prestigious 2010 IEEE Medal for Innovations in Healthcare Technology for the design, commercial development and clinical implementation of the PET/CT scanner. Prof Townsend will receive the medal jointly with his co-inventor, engineer Ronald Nutt, on 26 June 2010 at the IEEE Honors Ceremony in Montreal, Quebec, Canada. IEEE is the world's largest professional association advancing technology for humanity.

23 Jun 2010

Corgenix receives new European patent for AtherOx technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

23 Jun 2010

World Bank provides over $63M for multi-country lab network in East Africa region

East African Business Week/allAfrica.com reports on the recent decision by the World Bank to back the creation of "a unique regional network of 25 public health laboratories" in Kenya, Tanzania, Uganda and Rwanda with $63.66 million in support.

23 Jun 2010

Proven Diagnostics signs contract to provide comprehensive laboratory services to Highmark members

Proven Diagnostics, a clinical diagnostic laboratory located in Bethlehem, Pa., announced today that it has signed a contract with Highmark, the largest health insurer in Pennsylvania.

23 Jun 2010

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Probactive Biotech, Inc., a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds. Antitumor antibodies have the ability to take antitumor compounds directly to the tumor sites within the body.

22 Jun 2010

Concord Medical adds two new centers by furthering partnership with Navy General Hospital

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will add two new centers to its extensive network by furthering its partnership with the PLA Navy General Hospital, located in Beijing.

22 Jun 2010

Michigan State University researchers analyze histiocytic sarcomas

Michigan State University veterinarians are taking part in a two-year, $5.3 million project to analyze five cancers in dogs, research that could offer new insight into canine cancer genes and their potential impact on the human form of the disease.

22 Jun 2010

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

By combining two relatively inexpensive technologies based on sound and light waves, researchers hope to lower the rate at which women undergo breast biopsies for suspicious lesions. Results of the study on ultrasound-guided optical tomography are published in the online edition and the August print issue of Radiology.

22 Jun 2010

Cernostics, Geisinger announce personalized healthcare collaboration

Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.

22 Jun 2010

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

The U.S. Food and Drug Administration today approved the first assay to detect both antigen and antibodies to Human Immunodeficiency Virus. This assay is approved for use as an aid in the diagnosis of HIV-1/HIV-2 infection in adults including pregnant women. It is also the first assay for use as an aid in the diagnosis of HIV-1/HIV-2 infection in children as young as two years old.

22 Jun 2010

Angeion launches new TRUcal resting metabolic rate system

Angeion Corporation announced that it has launched its new TRUcal™ resting metabolic rate system. Part of its New Leaf® product line, TRUcal includes an analyzer that gently measures one's breath for oxygen and carbon dioxide which gives consumers their true individualized daily calories their body requires. The TRUcal™ system also includes a compact netbook with Bluetooth® technology, adding the benefit of wireless connectivity.

21 Jun 2010

CardioGenics announces clinical test sites for QL Care portable blood analyzer

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.

21 Jun 2010

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

Every nine and a half minutes, someone in the United States is infected with HIV, and one out of every five of these individuals doesn't know it. To help stem the spread of this disease, the U.S. Food and Drug Administration (FDA) today approved an innovative new diagnostic tool, which will allow patients to be diagnosed earlier than ever before.

21 Jun 2010

Saladax Biomedical, Bristol-Myers Squibb collaborate to develop clinical diagnostics

Saladax Biomedical, Inc. announced today that it has entered into a multi-year development and commercialization agreement with Bristol-Myers Squibb Company for the development of certain clinical diagnostic tests to be used in conjunction with the development of certain therapeutic compounds in the Bristol-Myers Squibb pipeline.

21 Jun 2010

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Omnyx, a leader in digital pathology solutions, announced today that they have entered into a three-year agreement to develop clinical algorithms for digital pathology. The aim is to support pathologists in generating even more accurate, objective and reproducible diagnostic results.

21 Jun 2010

Diagnostic News and Research

MDI raises $1.4M as part of follow-on to its $3.3M Series C financing round

German IVF Register reports one-millionth treatment cycle in reproductive medicine

imec researchers demonstrate biosensors that detect extremely low concentrations of disease markers

Toshiba announces availability of Aegis breast imaging workstation with MR products

A*STAR physicist receives prestigious 2010 IEEE Medal for Innovations in Healthcare Technology

Corgenix receives new European patent for AtherOx technology

World Bank provides over $63M for multi-country lab network in East Africa region

Proven Diagnostics signs contract to provide comprehensive laboratory services to Highmark members

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Concord Medical adds two new centers by furthering partnership with Navy General Hospital

Michigan State University researchers analyze histiocytic sarcomas

Ultrasound-guided diffuse optical tomography holds promise for ascertaining early-stage invasive breast cancer

Cernostics, Geisinger announce personalized healthcare collaboration

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

Angeion launches new TRUcal resting metabolic rate system

CardioGenics announces clinical test sites for QL Care portable blood analyzer

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

Saladax Biomedical, Bristol-Myers Squibb collaborate to develop clinical diagnostics

Dako, Omnyx partner to develop clinical algorithms for digital pathology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News